|
Market Closed -
Nasdaq
00:00:00 21/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 807.48 USD | +3.25% |
|
+7.22% | +4.61% |
| 10-20 | AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial | RE |
| 10-19 | Major drugmakers turn to China for licensing deals | RE |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Tradegate
| RGO | Real-time | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Lima
| REGNUS | End-of-day quote | |
Sao Paulo
| REGN34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 852.03 | 852.03 | 834.04 |
| Spread/Res. | -5.23% | -5.23% | -3.18% |
| Spread/Supp. | +6.49% | +11.99% | +12.95% |
| Support | 758.27 | 721.05 | 714.89 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
